Background illustration for clinical trials search

Paid Clinical Trials Greensboro

Discover 1,825 paid clinical trials in Greensboro, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

SPYRAL GEMINI Pilot Study

for
Hypertension, Vascular Diseases, Cardiovascular Diseases,
Location: Chapel Hill NC, Atlanta GA, Camden NJ, Southfield MI,
Sponsor: Medtronic Vascular

Sex: All

Age: 18 - 70+

Code: NCT06907147

Recruiting

Telerehabilitation In The Home After Stroke

for
Stroke
Location: Chapel Hill NC, Durham NC, Charleston SC,
Sponsor: University of California, Los Angeles

Sex: All

Age: 18 - 70+

Code: NCT06682429

Recruiting

Study of Biomarker-Based Treatment of Acute Myeloid Leukemia

for
Previously Untreated Relapsed Refractory Acute Myeloid Leukemia
Location: Chapel Hill NC, Morgantown WV, Baltimore MD, Atlanta GA,
Sponsor: Beat AML, LLC

Sex: All

Age: 18+

Code: NCT03013998

Phase 2, Phase 3, Recruiting

Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers

for
Diabetic Foot Ulcer
Location: Chapel Hill NC, Augusta GA, McKeesport PA, Columbus OH,
Sponsor: Piomic Medical

Sex: All

Age: 22 - 70+

Code: NCT05758545

Recruiting

IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study)

for
Acute Myeloid Leukemia
Location: Chapel Hill NC, Columbus OH, Dallas TX, Aurora CO
Sponsor: Alice Mims

Sex: All

Age: 18+

Code: NCT05401097

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

STRIDE Biorepository

for
Anemia, Sickle Cell
Location: Chapel Hill NC, Durham NC, Charlottesville VA,
Sponsor: Emory University

Sex: All

Age: 15 - 40

Code: NCT02843347

Recruiting

Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma

for
Relapsed Multiple Myeloma, Refractory Multiple Myeloma
Location: Chapel Hill NC, Atlanta GA, Detroit MI, Rochester NY,
Sponsor: Opna Bio LLC

Sex: All

Age: 18+

Code: NCT06433947

Phase 1, Recruiting

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

for
Ovarian Cancer
Location: Chapel Hill NC, Towson MD, Savannah GA, Lancaster PA,
Sponsor: Daiichi Sankyo

Sex: Female

Age: 18+

Code: NCT06819007

Phase 3, Recruiting

Optimizing Telehealth-delivery of a Weight Loss Intervention in Older Adults

for
Obesity, Multiple Chronic Conditions
Location: Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill

Sex: All

Age: 65 - 70+

Code: NCT06044571

Recruiting
New

Physiology-directed Epinephrine Dosing in Pediatric Cardiac Arrest

for
Cardiac Arrest (CA)
Location: Chapel Hill NC, Richmond VA, Atlanta GA, Columbus OH,
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0 - 18

Code: NCT07890610

Recruiting

Inspiring New Science In Guiding Healthcare in Turner Syndrome Registry

for
Turner Syndrome
Location: Chapel Hill NC, Washington DC, Columbus OH,
Sponsor: University of Colorado, Denver

Sex: Female

Age: 0+

Code: NCT05052606

Recruiting

A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature

for
Idiopathic Short Stature
Location: Chapel Hill NC, Columbia SC, Washington D.C. DC,
Sponsor: BioMarin Pharmaceutical

Sex: All

Age: 3 - 11

Code: NCT06382155

Phase 2, Recruiting

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

for
Type 2 Diabetes
Location: Chapel Hill NC, Columbia SC, Greenville SC,
Sponsor: Eli Lilly and Company

Sex: All

Age: 10 - 17

Code: NCT06739122

Phase 3, Recruiting

Optimal Ventilation for Cardiac Arrest

for
Cardiac Arrest (CA)
Location: Chapel Hill NC, Richmond VA, Atlanta GA, Columbus OH,
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0 - 18

Code: NCT07114510

Recruiting

Rehabilitation Outcomes Study

for
Cancer, Malignant Tumor
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06674889

Recruiting

Combating Cancer-Related Fatigue: A Personalized Supportive Care Program

for
Indolent Lymphomas, Lymphoma, Chronic Lymphocytic Leukemia,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06860880

Recruiting

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

for
B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma,
Location: Chapel Hill NC, Columbus OH, Nashville TN,
Sponsor: Vironexis Biotherapeutics Inc.

Sex: All

Age: 13 - 70+

Code: NCT06533579

Phase 1, Phase 2, Recruiting

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

for
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma,
Location: Chapel Hill NC, Salem VA, Atlanta GA, Pittsburgh PA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07221149

Phase 2, Phase 3, Recruiting

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
Location: Chapel Hill NC, Durham NC, Charlottesville VA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06119581

Phase 3, Recruiting

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

for
Hematologic Malignancies
Location: Chapel Hill NC, Greenville SC, Newnan GA, Birmingham AL,
Sponsor: Sellas Life Sciences Group

Sex: All

Age: 12+

Code: NCT04588922

Phase 1, Phase 2, Recruiting